Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme

Glioblastoma multiforme (GBM) is the most aggressive brain tumor and has a poor prognosis and is poorly sensitive to radiotherapy or temozolomide (TMZ) chemotherapy. Therefore, identifying new biomarkers to predict therapeutic responses of GBM is urgently needed. By using The Cancer Genome Atlas (TC...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Lee, Hsun-Hua, Lin, Che-Hsuan, Lin, Hui-Yu, Kuei, Chia-Hao, Zheng, Jing-Quan, Wang, Yuan-Hung, Lu, Long-Sheng, Lee, Fei-Peng, Hu, Chaur-Jong, Wu, Dean, Lin, Yuan-Feng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7016639/
https://ncbi.nlm.nih.gov/pubmed/31906036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010098
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak